A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
MEDICAL PROPERTIES TRUST INC
MPW
$3.1B
Mkt Cap
MEDICAL PROPERTIES TRUST INC (MPW) has a 5-year average return on invested capital (ROIC) of -0.8%. This is below average and may indicate limited pricing power.
MEDICAL PROPERTIES TRUST INC (MPW) has a market capitalization of $3.3B. It is classified as a mid-cap stock.
Yes, MEDICAL PROPERTIES TRUST INC (MPW) pays a dividend with a trailing twelve-month yield of 5.83%. The company also returns capital through share buybacks, with a buyback yield of 0.71%.
MEDICAL PROPERTIES TRUST INC (MPW) operates in the Real Estate Investment Trusts industry, within the Real Estate sector.
MEDICAL PROPERTIES TRUST INC (MPW) reported annual revenue of $972 million in its most recent fiscal year, based on SEC EDGAR filings.
MEDICAL PROPERTIES TRUST INC (MPW) has a net profit margin of -28.5%. The company is currently unprofitable.
MEDICAL PROPERTIES TRUST INC (MPW) generated $89 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
We are a self-advised REIT formed in 2003 to acquire and develop net-leased healthcare facilities. At December 31, 2024, we had investments in 396 facilities and approximately 39,000 licensed beds in 31 states in the U.S., seven countries in Europe, and Colombia in South America. We have operated as a REIT since April 6, 2004, and accordingly, elected REIT status upon the filing of our calendar year 2004 federal income tax return. Medical Properties Trust, Inc. was incorporated under Maryland law on August 27, 2003, and MPT Operating Partnership, L.P. was formed under Delaware law on September 10, 2003. We conduct substantially all of our business through MPT Operating Partnership, L.P. Our primary business strategy is to acquire and develop healthcare facilities and lease the facilities to healthcare operating companies under long-term net leases, which require the tenant to bear most of the costs associated with the property.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 972M | 972M | - | 872M | 1.5B | 1.5B |
| Net Income | -277M | -277M | -2.4B | -556M | 903M | 656M |
| EPS | $-0.46 | $-0.46 | $-4.02 | $-0.93 | $1.50 | $1.11 |
| Free Cash Flow | 89M | 89M | 140M | 271M | -594M | -4.5B |
| ROIC | 1.6% | 2.0% | -15.4% | -3.0% | 6.5% | 5.6% |
| Gross Margin | 41.5% | 41.5% | - | 55.8% | 66.8% | 71.8% |
| Debt/Equity | 2.11 | 2.11 | 1.83 | 1.32 | 1.19 | 1.34 |
| Dividends/Share | $0.32 | $0.33 | $0.46 | $0.88 | $1.16 | $1.12 |
| Operating Income | 272M | 272M | -1.9B | -276M | 1.3B | 1.1B |
| Operating Margin | 28.0% | 28.0% | - | -31.7% | 85.4% | 71.0% |
| ROE | -6.0% | -5.9% | -38.7% | -6.9% | 10.6% | 8.3% |
| Shares Outstanding | 602M | 602M | 600M | 598M | 602M | 591M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 313M | 442M | 541M | 705M | 785M | 854M | 1.2B | 1.5B | 1.5B | 872M | N/A | 972M | 972M |
| Gross Margin | 4.7% | 3.5% | 1.1% | 77.2% | 71.2% | 62.0% | 75.5% | 71.8% | 66.8% | 55.8% | N/A | 41.5% | 41.5% |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | 37M | 44M | 49M | 59M | 81M | 96M | 132M | 146M | 160M | 146M | 134M | 130M | 130M |
| EBIT | 143M | 263M | 342M | 486M | 1.2B | 610M | 791M | 1.1B | 1.3B | -276M | -1.9B | 272M | 272M |
| Op. Margin | 45.7% | 59.6% | 63.1% | 68.9% | N/A | 71.4% | 63.3% | 71.0% | 85.4% | -31.7% | N/A | 28.0% | 28.0% |
| Net Income | 51M | 140M | 225M | 290M | 1.0B | 375M | 431M | 656M | 903M | -556M | -2.4B | -277M | -277M |
| Net Margin | 16.2% | 31.6% | 41.6% | 41.1% | 129.6% | 43.9% | 34.5% | 42.5% | 58.5% | -63.8% | N/A | -28.5% | -28.5% |
| Non-Recurring | 50M | 2.8M | 7.2M | 5.3M | 48M | 21M | 19M | 41M | 0 | 0 | 180M | 0 | 0 |
| Returns on Capital | |||||||||||||
| ROIC | 4.6% | 6.0% | 6.0% | 6.6% | 15.2% | 6.0% | 5.2% | 5.6% | 6.5% | -3.0% | -15.4% | 2.0% | 1.6% |
| ROE | 3.7% | 8.0% | 8.4% | 8.2% | 24.3% | 6.5% | 6.0% | 8.3% | 10.6% | -6.9% | -38.7% | -5.9% | -6.0% |
| ROA | 1.5% | 3.0% | 3.7% | 3.8% | 11.4% | 3.2% | 2.8% | 3.5% | 4.5% | -2.9% | -14.8% | -1.9% | -1.8% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 150M | 207M | 264M | 362M | 449M | 494M | 618M | 812M | 739M | 506M | 245M | 231M | 231M |
| Free Cash Flow | -617M | -2.0B | -1.4B | -1.9B | -982M | -4.1B | -3.6B | -4.5B | -594M | 271M | 140M | 89M | 89M |
| Owner Earnings | 86M | 124M | 158M | 220M | 291M | 305M | 295M | 426M | 344M | -144M | -241M | -68M | -68M |
| CapEx | 768M | 2.2B | 1.7B | 2.2B | 1.4B | 4.6B | 4.2B | 5.4B | 1.3B | 235M | 106M | 142M | 142M |
| Maint. CapEx | 55M | 72M | 98M | 132M | 141M | 157M | 276M | 334M | 346M | 616M | 454M | 273M | 273M |
| Growth CapEx | 713M | 2.1B | 1.6B | 2.1B | 1.3B | 4.4B | 4.0B | 5.0B | 987M | 0 | 0 | 0 | 0 |
| D&A | 55M | 72M | 98M | 132M | 141M | 157M | 276M | 334M | 346M | 616M | 454M | 273M | 273M |
| CapEx/OCF | 510.3% | 1071.9% | 637.7% | 620.3% | 318.6% | 924.0% | 688.0% | 659.2% | 180.4% | 46.5% | 43.0% | 61.6% | 61.6% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 144M | 183M | 218M | 327M | 364M | 412M | 568M | 643M | 699M | 615M | 321M | 193M | 193M |
| Dividend Yield | 14.5% | 13.6% | 12.5% | 13.2% | 12.2% | 8.4% | 8.7% | 7.6% | 9.7% | 16.0% | 13.3% | 6.8% | 5.8% |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18M | 0 | 0 | 23M | 23M |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.4% | N/A | N/A | 0.8% | 0.7% |
| Stock-Based Comp | 9.2M | 11M | 7.9M | 9.9M | 17M | 32M | 47M | 52M | 49M | 33M | 33M | 26M | 26M |
| Debt Repayment | 100M | 283K | 575M | 1.0B | 0 | 0 | 800M | 1.4B | 870M | 988M | 702M | 2.3B | 2.3B |
| Balance Sheet | |||||||||||||
| Net Debt | 2.1B | 3.2B | 2.8B | 4.7B | 3.2B | 5.6B | 8.3B | 10.8B | 10.0B | 9.8B | 8.5B | 9.2B | 9.2B |
| Cash & Equiv. | 145M | 196M | 83M | 171M | 821M | 1.5B | 550M | 459M | 236M | 250M | 332M | 541M | 541M |
| Long-Term Debt | 2.2B | 3.3B | 2.9B | 4.9B | 4.0B | 7.0B | 8.9B | 11.3B | 10.3B | 10.1B | 8.8B | 9.7B | 9.7B |
| Debt/Equity | 1.59 | 1.59 | 0.90 | 1.28 | 0.89 | 1.00 | 1.21 | 1.34 | 1.19 | 1.32 | 1.83 | 2.11 | 2.11 |
| Interest Coverage | 1.5 | 2.2 | 2.1 | 2.7 | 5.6 | 2.6 | 2.4 | 3.0 | 3.7 | -0.7 | -4.7 | 0.5 | 0.5 |
| Equity | 1.4B | 2.1B | 3.2B | 3.8B | 4.5B | 7.0B | 7.3B | 8.4B | 8.6B | 7.6B | 4.8B | 4.6B | 4.6B |
| Total Assets | 3.7B | 5.6B | 6.4B | 9.0B | 8.8B | 14.5B | 16.8B | 20.5B | 19.7B | 18.3B | 14.3B | 15.0B | 15.0B |
| Total Liabilities | 2.3B | 3.5B | 3.2B | 5.2B | 4.3B | 7.4B | 9.5B | 12.1B | 11.1B | 10.7B | 9.5B | 10.4B | 10.4B |
| Intangibles | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | -361M | -419M | -434M | -486M | 163M | 83M | -71M | -88M | 116M | -972M | -3.7B | -4.1B | -4.1B |
| Working Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Liabilities | N/A | N/A | 208M | N/A | N/A | N/A | N/A | 608M | 621M | N/A | N/A | 549M | 549M |
| Per Share Data | |||||||||||||
| EPS | 0.29 | 0.63 | 0.86 | 0.82 | 2.76 | 0.87 | 0.81 | 1.11 | 1.50 | -0.93 | -4.02 | -0.46 | -0.46 |
| Owner EPS | 0.49 | 0.56 | 0.60 | 0.62 | 0.79 | 0.71 | 0.55 | 0.72 | 0.57 | -0.24 | -0.40 | -0.11 | -0.11 |
| Book Value | 7.93 | 9.49 | 12.41 | 10.81 | 12.34 | 16.32 | 13.78 | 14.28 | 14.28 | 12.75 | 8.06 | 7.65 | 7.65 |
| Cash Flow/Share | 0.86 | 0.93 | 1.01 | 1.02 | 1.22 | 1.15 | 1.16 | 1.37 | 1.23 | 0.85 | 0.41 | 0.38 | -0.01 |
| Dividends/Share | 0.84 | 0.88 | 0.91 | 0.96 | 1.00 | 1.02 | 1.08 | 1.12 | 1.16 | 0.88 | 0.46 | 0.33 | 0.32 |
| Shares Out. | 174.2M | 221.6M | 261.7M | 353.4M | 368.4M | 430.7M | 532.7M | 591.0M | 601.7M | 598.4M | 599.6M | 602.3M | 602.3M |
| Valuation | |||||||||||||
| P/E Ratio | 21.5 | 8.9 | 7.3 | 9.3 | 3.5 | 15.0 | 17.7 | 14.5 | 5.6 | N/A | N/A | N/A | -12.0 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 9.6 | 15.0 | 34.5 | 37.4 |
| EV/EBIT | 22.0 | 16.7 | 13.1 | 15.3 | 9.9 | 370.7 | N/A | 341.5 | 47.8 | N/A | N/A | N/A | 45.9 |
| Price/Book | 0.8 | 0.6 | 0.5 | 0.7 | 0.8 | 0.8 | 1.0 | 1.1 | 0.6 | 0.3 | 0.4 | 0.7 | 0.7 |
| Price/Sales | 3.2 | 3.0 | 3.2 | 3.5 | 3.8 | 5.7 | 5.2 | 5.5 | 4.7 | 4.4 | N/A | 2.9 | 3.4 |
| FCF Yield | -56.8% | -162.7% | -86.8% | -69.6% | -27.9% | -72.6% | -47.5% | -47.6% | -11.8% | 10.5% | 6.7% | 2.9% | 2.7% |
| Market Cap | 1.1B | 1.2B | 1.6B | 2.7B | 3.5B | 5.6B | 7.7B | 9.5B | 5.0B | 2.6B | 2.1B | 3.1B | 3.3B |
| Avg. Price | 5.73 | 6.08 | 6.67 | 7.00 | 8.11 | 11.35 | 12.31 | 14.36 | 11.97 | 6.43 | 4.03 | 4.70 | 5.50 |
| Year-End Price | 6.24 | 5.58 | 6.25 | 7.66 | 9.54 | 13.02 | 14.36 | 16.12 | 8.35 | 4.33 | 3.49 | 5.08 | 5.50 |
MEDICAL PROPERTIES TRUST INC passes 2 of 9 quality checks, indicating weak fundamentals.
On a free-cash-flow basis, the stock trades at 37.4x vs a median of 15.0x. The company's 5-year average gross margin is 59.0%. Total shareholder yield (dividends + buybacks) is 6.5%. At current prices, the estimated annualized return to fair value is +0.9%.
MEDICAL PROPERTIES TRUST INC (MPW) has a debt-to-equity ratio of 2.11. This indicates higher leverage, which may increase financial risk.
MEDICAL PROPERTIES TRUST INC (MPW) reported earnings per share (EPS) of $-0.46 in its most recent fiscal year.
MEDICAL PROPERTIES TRUST INC (MPW) has a return on equity (ROE) of -5.9%. A negative ROE may indicate losses or negative equity.
MEDICAL PROPERTIES TRUST INC (MPW) has a 5-year average gross margin of 59.0%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 17 years of financial data for MEDICAL PROPERTIES TRUST INC (MPW), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
MEDICAL PROPERTIES TRUST INC (MPW) has a book value per share of $7.65, based on its most recent annual SEC filing.